secretion. In rats immunized with gonadotrophin-releasing The effects of follicle stimulating hormone (FSH) treatment hormone (GnRH), in which all germinal cell types were on the quality of human spermatozoa were assessed by significantly reduced, recombinant FSH increased the numbers examining the ultrastructure and the function of infertile of those cell types at an earlier stage to elongated spermatids, human spermatozoa using a previously-defined formula.
restoring spermatogenesis and increasing the number of spermUsing the spermatozoa as an andrological monitor shows atogonia as well as promoting the subsequent maturational that the therapeutic effect of FSH depends on the type of steps (McLachlan et al., 1995) . sperm defect. The response to FSH is, in many cases, These fundamental results are part of a rich line of studies positive and can be evaluated by examining the state of which demonstrated, in the early 1970s, a considerable associthe ejaculated spermatozoa. From an initial group of 81 ation between destruction of human germinal epithelium and patients, 15 were placebo-treated controls, and 19 were elevated concentrations of FSH in plasma and urine (e.g. non-responders (mainly with microbially infected semen). Rosen and Weintraub, 1971; Franchimont et al., 1972 ; Leonard Out of 47 responders, after therapy nine achieved improved et al., 1972; Kjessler and Wide, 1973; de Kretser et al., 1974 , sperm quality which approached the natural fertility Hunter et al., 1974; Zarate et al., 1974; Christiansen et al., threshold. These responders all had spermatozoa affected 1975). These data were compared with the histological state by immaturity or apoptosis (n ⍧ 27). The 20 microbiallyof the testis. In azoospermic men the plasma FSH concentration infected responders also had immature spermatozoa and appeared as a good marker of spermatogenesis, while the never achieved the quality level of natural fertility. Thus, testosterone value seemed unrelated (Bablok et al., 1978) . a natural fertility level was only achieved by nine respondHowever, more recently Bergmann et al. (1994) found that a ers out of 27 (three with immature spermatozoa, and six normal FSH value does not exclude severe derangement of with apoptotic spermatozoa). Using our method of sperm spermatogenesis; similarly Bar-On et al. (1995) and Martinanalysis, these patients' spermatozoa were clearly categordu- Pan and Bischof (1995) confirmed that FSH cannot be used ized before treatment as either immature or apoptotic. In for diagnosis of Sertoli cell-only syndrome, and that an elevated consequence, the success of the therapy was predictable.
FSH concentration is insufficient to indicate a damaged gerThe response of individual organelles to therapy was minal epithelium. More recently Comhaire et al. (1995) , examined. Certain qualities of the acrosome, the chromatin, Mahmoud et al. (1996) , Mannaerts et al. (1996) and Anderson the mitochondria, and the axoneme appear to be sensitive et al. (1996) used the inhibin peak as a parameter of Sertoli to FSH. Most of the previous conflicting results reported cell function during infertility treatment with urinary or recomin the literature may be due to a lack of relevant discriminabinant FSH. However, Gil-Salom et al. (1996) found that the tion between the different defects present in the spermato-FSH concentration is not correlated with the ability of human zoa of the patients, without assessing the likelihood of their ejaculated or testicular spermatozoa to achieve in-vitro fertilizaresponse.
tion (IVF) by intracytoplasmic sperm injection (ICSI). It is Key words: FSH treatment/human spermatozoa/infertility/ interesting to observe that FSH has circannual variations mathematics/ultrastructure related to environmental conditions (Meriggiola et al., 1996) . At the same time, the effect of FSH treatment on sterile men was further assessed. Mastrogiacomo et al. (1991) examined sperm number and motility, and found a slow influence Introduction of the treatment in hypogonadotrophic hypogonadic subjects.
More recently Acosta et al. (1991 Acosta et al. ( , 1992 treated men with Follicle stimulating hormone (FSH) has a role in the development of the immature testis, but its importance in the maintensevere male factor infertility with pure FSH, but no significant the hormonal status. The following exclusion criteria were applied:
changes were observed after the therapy, either in the endocrine testicular tumour; presence of any major systemic disease; surgical profile or in the basic semen parameters, although the fertility or medical condition which in the judgement of the investigator might rate appeared drastically improved. Russel et al. (1993) Singh and Handelsman (1996) tested Pharmaceuticals, Germany). FSH was administered s.c. and local recombinant FSH on gonadotrophin-deficient mice and found tolerance was assessed at regular intervals. The remaining group of that it stimulated initial spermatogenesis.
15 men was treated with saline placebo. All patients gave informed A recent further interpretation of the role of FSH in the consent (including the 18% probability of placebo treatment).
testis was furnished by Tapanainen et al. (1993) , Callard et al.
At the end of the therapy hormonal parameters were evaluated. No (1995), Henriksen et al. (1995) and Brinkworth et al. (1995) , adverse side-effects were observed. who showed how the well known phenomenon of apoptosis (Kerr et al., 1972; Wyllie et al., 1980; Wyllie, 1987; Williams Semen analysis and Smith, 1993; Schwartzmann and Cidlowski, 1993) 
occurs
Light microscopy: Volume, sperm concentration and motility were widely in the rat seminiferous epithelium, from spermatogonia evaluated before therapy, and after 12 and 18-24 weeks after its to spermatids and it is controlled by the presence of FSH commencement. Semen samples were collected by masturbation after (Tapanainen et al., 1993; Billig et al., 1995 (1996) using electron microscopy and the TdT mediated dUTPined before therapy, after 12 weeks of therapy and 6-12 weeks after biotin nick end labelling (TUNEL) technique found that mature its cessation. Ejaculates were fixed in cold Karnovsky (1965) fluid spermatozoa in the ejaculate of infertile men were often and maintained at 4°C for 2 h. The fixed semen was then centrifuged apoptotic. In particular, patients affected by seminoma or at 3000 g for 15 min. The pellet was washed in 0.1 M cacodylate immaturity had up to 50% apoptotic spermatozoa, while the buffer (pH 7.2) for 12 h, post-fixed for 1 h at 4°C in 1% buffered presence of infections or varicocele was correlated with 10% osmium tetroxide, dehydrated and embedded in Epon-Araldite. The apoptotic spermatozoa.
sections cut with an ultramicrotome Supernova (Reickert Jung, All these papers seem to suggest (Zirkin et al., 1994) that Vienna, Austria) were collected on copper grids, stained with uranyl the role of FSH in the maintenance of adult spermatogenesis acetate and lead citrate, and observed and photographed with a Philips CM10 electron microscope (Philips Scientifics, Eindhoven, The is still controversial, and that the positive role of FSH treatment Netherlands). The numerical observations were reported on approin improving sperm quality is still subject to discussion, and priate forms (Figure 1 ) from which a mathematical evaluation was finally that the role of FSH in controlling apoptosis of male subsequently carried out. The placebo-treated patients, as well as germinal epithelium is generally accepted. those treated with FSH at different stages of the therapy, were
We assessed the action of pure FSH treatment on the semen observed by four different evaluators blinded to the treatment, in quality of sterile men, using electron microscopy according to order to exclude any subjective component. the formula of Baccetti et al. (1995) to examine sperm structure and function by statistical analysis.
Statistical analysis
The mathematical formula of Baccetti et al. (1995) was used; this evaluates structural and functional sperm integrity by computerizing
Materials and methods
the submicroscopical characteristics detected by TEM. The formula Patients is valid for a real system of 15 variables and allows a precise simultaneous evaluation of the sperm characteristics and a determinaThis study included the male partners of couples attending the tion of the total number and the percentage of spermatozoa free from Gynecological Clinic of Ulm, Germany, in whom the results of ultrastructural defects present in the ejaculates. The means of the combined gynaecological and andrological exminations had indicated percentages of healthy spermatozoa and the means of the percentage the presence of male factor infertility.
of the single characters of the sperm organelles, calculated in The group age range was 30-40 years and none had fathered a the different stages of the experiment, were compared. Statistical child or initiated a pregnancy over a period of at least 2 years significance of the difference between the means of the groups was unprotected sexual intercourse. A total of 81 selected patients underwent a complete physical examination and a baseline evaluation of assessed by Student's paired t-test. Significance was set at P ഛ0.05. according to the sperm ultrastructure (Table II) 12 weeks placebo treatment
Immaturity-related defects (n ϭ 4) Apoptosis (n ϭ 4) 68 328 0.080
The acrosomes had sparse contents and were located far from 
Infection-related defects (n ϭ 35)
The spermatozoa ( Figure 3 ) had swollen acrosome and mitoing the dynein arms, the fibrous sheath and the accessory fibres were disrupted. Severe bacterial contamination was chondria. The majority of nuclei were disrupted and fragmented, according to the three pathological stages of pyknosis, present. This complex of defects indicated the presence of diffuse, progressive necrosis. Those patients exhibiting both karyorrhexys and karyolysis. The axonemal structures, includ- Longitudinal and cross-sections of spermatozoa from patients affected by semen immaturity, before therapy with follicle stimulating hormone (FSH). The characteristic defects are: badly shaped acrosomes (aA) (A, B, C), sometimes located far from nucleus (A); altered nuclei with uncondensed chromatin (uCh) (A, B, C); presence of large cytoplasmic residues (CR) (A, B, C, D) with rolled up altered axonemes (aAx) and irregularly assembled mitochondrial helix (aMh) (A, C). In D some microtubular doublets are devoid of one or both dynein arms (short arrows); also two accessory fibres are absent (long arrows) and the fibrous sheath (Fs) is poor. Original magnification: A and B, ϫ17 300; C ϫ10 500; D ϫ7400.
immaturity and infection-related defects were categorized
Antisperm autoantibodies (n ϭ 1) according to the predominant defect. Macrophages were usually This appeared in the form of flocculent material juxtaposed to frequent and contained variously digested sperm organelles in the plasma membrane ( Figure 5A ). their cytoplasm.
Immature spermatid stages only (n ϭ 3) Apoptotic germinal cells (n ϭ 23) These patients ( Figure 5B ) had uncondensed, non-vacuolized Ejaculated spermatids and spermatozoa ( Figure 4 ) frequently sperm chromatin, poorly developed acrosomes, large cytorevealed typical apoptotic nuclei in which the chromatin was plasmic residues, incorrectly assembled mitochondria, rolled aggregated into large compact granular masses close to the tails and high percentages of double or multiple forms. well-conserved nuclear envelope. Sometimes all the chromatin was aggregated into a single mass which occupied a portion The 15 patients treated by placebo (analysed according to of the nuclear space. In the cytoplasm translucent vacuoles Baccetti et al., 1995) had a mean of 113 814 spermatozoa free were present and all the mitochondria were aggregated (Figure from defects (0.09%). Six individuals belonged to the first 4C). Axonemes and related tail structures were frequently category ( Figure 5C ), four to the second category and five to found incorrectly assembled ( Figure 5F ) in spermatids, and the third category (Table II) . incompletely assembled in spermatozoa ( Figure 5E ). Usually
The structural characteristics of spermatozoa after 12 weeks bacterial contamination was not present, but actively phagoof FSH treatment: non-responders and responders cytosing macrophages were frequent and generally contained Ejaculates were examined after 12 weeks of treatment by elecclassic sperm apoptotic nuclei which were clearly distinguishable from necrotic nuclei. tron microscopy. On initial inspection it appeared that the condi- tion of the semen from the 66 patients had drastically improved; kinds of reaction to the FSH treatment should be present. In order to analyse the phenomenon further, we divided the patients applying the formula of Baccetti et al. (1995) gave a mean of 533 837 healthy spermatozoa in the total ejaculate, compared into two groups according to their improvement following therapy: (i) responders (n ϭ 47); and (ii) non-responders (n ϭ 19). with pre-treatment figures (Table I ). The complex of structural qualities appeared to have improved by a coefficient of 5.
The 47 responders had a mean of 79 548 healthy spermatozoa (0.163%) in the total ejaculate before therapy, which rose to a Immaturity characteristics were considerably improved ( Figure 6A ). Infection-related necrosis remained more or less mean of 570 024 healthy spermatozoa (1.717%) after 12 weeks of therapy (P Ͻ 0.05; Table III) . the same (Figure 3) . However, sperm organelles had suffered significantly less apoptosis ( Figures 6B,C,D) . Neither the patient
In the 19 non-responders, the mean of total numbers of healthy spermatozoa of the entire ejaculate was 217 039 with antisperm autoantibodies (Figure 5A ), nor the three patients with spermatogenic arrest ( Figure 5B ) responded to treatment.
(0.389%) before therapy, which decreased to 66 532 (0.131%) after 12 weeks of therapy (Table III) . This suggests that, for overall success of the therapy, two major In responders the quality of healthy spermatozoa was 10
The spermatozoa of this group were generally mature, but times greater than previously, while non-responders had no with poor characteristics. In 90% of the cases, the acrosome positive reactions. This latter group may therefore possess a was generally disrupted, was poor in content, was small, factor which conflicts with the action of FSH, and is probably displaced, or abnormal. The chromatin was disrupted and the bacterial infection. Indeed this group showed clear evidence fragmented in~60-70% of cells causing the nuclear shape to of active bacteria in the ejaculate, and the presence of spermatobe irregular and abnormal. The mitochondria were swollen zoa with defects related to this. Of the 19 non-responders, 15
and abnormal in~80% of spermatozoa, and in 50% the had the microbially-infected semen, and the remaining four cytoskeleton of the tail was also abnormal. The plasma had either autoantibodies or azoospermia due to spermatomembrane was frequently broken. No significant change was genic arrest.
observed after the therapy. Thus spermatogenesis did not occur: the mean number of spermatozoa/ml simply diminished from Non-responders (n ϭ 19) 11.589ϫ10 6 to 9.400ϫ10 6 (Table IV) . Bacterial infection (n ϭ 15): Following treatment, the mean This picture represents that typical of infection, and demontotal number of healthy spermatozoa fell to~25% of that before treatment (Table III) .
strates a diffused insensitivity to FSH. This group includes the largest number of non-responders, and accounts for a large Spermatozoa absent or extremely immature (n ϭ 3): This condition indicates spermatogenic arrest and showed no change proportion of the initially infected group.
after treatment, suggesting total teratozoospermia, and an Spermatozoa carrying autoantibodies (n ϭ 1): Treatment almost total absence of healthy spermatozoa. FSH was comproduced no change in autoantibodies or the intense phenompletely inefficient. enon of agglutination. The sperm characteristics further deteriorated during the 3 months of treatment. The total number of Responders (n ϭ 47) This group of patients had a number of spermatozoa devoid healthy spermatozoa per ejaculate was reduced to~50% of those present before treatment (Table II) .
of ultrastructural defects (according to the formula of Baccetti et al., 1995) which were significantly improved by therapy. fertility; i.e. an increase from 4 254 204 to 7 756 482. A further patient approached this increase (1 418 714 healthy However, the level of fertility achieved varied, some patients spermatozoa). Almost 25% of these patients became fertile becoming fertile, while others achieved concentrations of after therapy. normal spermatozoa that simply assured a higher percentage of successful IVF attempts.
Immature spermatozoa (n ϭ 4): A mean of 1 309 009 (1.625%; The mean of healthy spermatozoa per ejaculate reached Table II ) healthy spermatozoa was achieved after therapy. 570 024 (1.717% Table III) ; P Ͻ 0.05 compared with pretreatThere was an improvement in structural defects: the presence of ment values. This group of patients included those initially cytoplasmic residues, of uncondensed chromatin and acrosome affected by apoptosis and immaturity; Ͼ50% of the infected ( Figure 6A ), of badly assembled tail organelles, typical of individuals fell into this group. immature cells. FSH treatment appeared to induce spermatogenesis, producing a larger number of spermatozoa (increased Apoptosis (n ϭ 23): Semen quality was largely improved: from 19.500ϫ10 6 to 22.500ϫ10 6 ) ( Table IV) . 1 197 823 healthy spermatozoa were present in the total Following therapy, two patients achieved sperm concentraejaculate (2.956%) (P Ͻ 0.005). The ultrastructural charactertions consistent with natural fertility (2 074 433 and 1 493 329). istics typical of apoptotic spermatozoa were significantly Thus, half of these patients became fertile. reduced ( Figures 6B,C,D) : immature, apoptotic cells were no longer present in the ejaculate, mature spermatozoa were better
Microbial infections (n ϭ 20):
The number of healthy spermastructured, and marginated chromatin ( Figure 6B ) was less tozoa increased to 76 583 (0.340%) following therapy (P Ͻ common. This suggests that the immature apoptotic forms had 0.01; Table II) . been eliminated while the number of normal spermatozoa had
In comparison with non-responders group of patients with increased. Following FSH treatment, four patients achieved a microbial infections, the same variety of defects was present, but at a lower frequency; immature forms diminished while healthy sperm concentration, within the range for natural teristics of the spermatozoa ( Figure 5C ) before treatment were remained almost in the same range as at the end of the therapy (1.339 versus 1.260%; not significant) ( Table I) that the total number of healthy spermatozoa strongly depends on the total number of spermatozoa in the ejaculate (Table  IV) , while the percentage represents only the incidence of The formula of Baccetti et al. (1995) showed that the structural immaturity 3 27 000 000 Non-responders 14 10 750 000 health of spermatozoa responds positively to the FSH treatment. We examined the reaction to therapy of the single organelles used in the formula. total sperm numbers increased (to a mean of 10.03ϫ10 6 /ml This analysis is limited to the spermatozoa of responder from 7.655ϫ10 6 /ml; Table IV ). This implies that infection patients before the beginning of the treatment and to those of drastically affected spermatogenesis and sperm maturation, the patients examined immediately after the conclusion of the and that FSH treatment increased the number of healthy therapy (12 weeks) provided that there was a significant spermatozoa among the more damaged cell population. This increase the number of healthy spermatozoa (Table III) . The category of patients represented those most severely affected, percentage of healthy spermatozoa remained fairly consistent having both infected and immature spermatozoa. Hence, sperm in the weeks subsequent to therapy (Table III) . In nonmaturation responded to FSH in the presence of continuing responders the complex of organelle characteristics remained infection. However, none of these patients showed improvethe same after treatment as before. In the responders we ment to the same extent as the two groups of patients with statistically compared the sperm organelles before and after apoptosis and immaturity, and none of them achieved normal FSH therapy in patients whose spermatozoa were categorized levels of fertility.
as immature, infected or apoptotic. We defined 16 submicroscopic ultrastructural characteristics Placebo-treated controls (n ϭ 15) This group of patients were examined by electron microscopy which could be either normal or affected by one or more defects (Figure 1 ). The total number of detected defects was after 12 weeks of treatment with placebo. The general charac- et al., 1995) . While the 16 characteristics of responders increased from 15.6% normal acrosomal shape to 26.3% following therapy (P Ͻ 0.01). No further progress normality are sufficient to guarantee the perfect functional state, the 32 abnormal characteristics can be used to classify occurred in the post-therapy weeks. some of the most important categories of sperm structural Acrosome of normal dimensions: The group with apoptotic alterations: it is simpler to diagnose health than disease. We spermatozoa improved with therapy from 25.5% normal acrohave included 20 characteristics in Table V , i.e. the 16 positive some dimensions to 36.9% (P Ͻ 0.05), which was maintained ones which guarantee fertility, plus the four negative ones during the post-therapy weeks (P Ͻ 0.01). In the group with indicating particular malformations. In our opinion, these 20 immature spermatozoa, there was no significant improvement characteristics shed some light on the structural state of the after therapy. The microbially-infected group had an initial spermatozoa.
(Baccetti
level of only 20% normal acrosomes which rose in responders to 33.1% (P Ͻ 0.01) after therapy. State: Single, or multiply-fused spermatozoa. Most (at least 92%) of the spermatozoa in every category are 'single'. This
Acrosome of normal content: The group of responders with characteristic was unaffected by FSH therapy even 6-12 apoptotic spermatozoa increased from 37.8% normal acrosomal weeks later. content to 50.4% (P Ͻ 0.05), and improvement continued, reaching 57.5% (P Ͻ 0.01) in the weeks following therapy. Acrosome in normal position: Only~20-50% of spermatozoa
The categories of immature and infected patients achieved no before therapy had a normally positioned acrosome. All others significant improvement. had more or less displaced acrosome. In apoptotic spermatozoa, 31.3% of acrosomes had normal position; after the therapy Absent or reacted acrosome: These two negative characters this rose to 40.6% (P Ͻ 0.05). About 6 weeks after the can be included together since the absence of an acrosome is cessation of the therapy the percentage improved to only identical morphologically to the acrosome reaction. Both 44.8% (not significant). In immature spermatozoa~50% of defects occurred mainly in the presence of phlogosis and acrosomes were well-positioned, which improved to 58% (not persisting infection. The genetic defect of absence of the significant) after therapy. There was no further improvement acrosome was not present in any patients in this study. After in the weeks post-therapy. In the infected spermatozoa, 22.5% FSH therapy, the absent or reacted acrosome significantly of acrosomes were in the normal position. In responders, this decreased in infected responders from 43.4 to 34% (P Ͻ 0.05). reached 40% after therapy (P Ͻ 0.01), with no further
In the immature category, there was no change since acrosomal improvement in subsequent weeks. degeneration was not related to immaturity. In the apoptotic group, there was also no significant change following therapy Acrosome of normal shape: Only about 15-32% of spermatozoa (from 39 to 32%). had a normal acrosomal form before therapy. In apoptotic or immature spermatozoa FSH therapy caused no significant
Nuclear shape: In all three groups of responders (apoptotic, immature and infected spermatozoa) this characteristic signiimprovement. However, in the microbially-infected group, the ficantly improved after FSH therapy (Table V) . This improve-0.01); the percentage 6 weeks after the end of FSH therapy started to decrease. ment did not continue in the post-therapy weeks. This characteristic is undoubtedly one of the most sensitive to
Normal pattern in the axoneme: Infertile patients frequently FSH therapy.
have a disturbed spermiogenesis resulting in patterns different from the classic 9 ϩ 2. In our three groups of responders, the Nucleus with compact chromatin: This characteristic improved classic pattern was present in 40-46% of the spermatozoa; following FSH therapy in all responders. In apoptotic and after FSH therapy these values did not increase significantly infected responder groups this condition improved (P Ͻ 0.05) in infected groups, but significantly to~55% in immature and after therapy (P Ͻ 0.01 in immature groups). There was a in apoptotic groups (P Ͻ 0.05). These values decreased after tendency to decrease in the post-therapy weeks.
therapy ceased.
Nucleus with marginated chromatin: This was crucial for the
Normal arms in the axoneme: A set of normal dynein arms diagnosis of apoptosis. The effect of FSH is well known and ( Figure 6D ) is essential for sperm movement, and in our three was confirmed by our figures. From an initial value of 33.5%, responder groups was present in~50% of spermatozoa before the percentage of apoptotic chromatin decreased to 18.05% (P therapy. After FSH therapy this value increased significantly Ͻ 0.005) after therapy, and remained at this level for 6 weeks in the immature sperm group (P Ͻ 0.05) and in the apoptotic after the cessation of therapy, showing this to be a major sperm group (P Ͻ 0.01), but not in the infected group. This improvement achieved by FSH therapy.
value decreased 6 weeks after cessation of the therapy. In the groups with immature and infected spermatozoa, the level of marginated chromatin was initially extremely low Normal shaped axoneme: An axoneme rolled up around the (Ͻ1%) and remained so after therapy.
sperm body (causing immotility) was present in 30-45% of spermatozoa in our three groups of patients and did not alter Nucleus with necrotic chromatin: This negative characteristic significantly with treatment. was a typical feature of necrosis as a consequence of infection. In the infected patients, the initial level of 26.6% disrupted Normal accessory fibres: The set of nine accessory fibres chromatin decreased to 20.3% after the therapy (P Ͻ 0.05), surrounding the 9 ϩ 2 axoneme is assembled during spermiosuggesting that the general improvement in spermatogenesis genesis. Following assembly, the fibres are fairly resistant to pathological events. In our three groups of patients, a mean affects chromatin necrosis in this group. The two other groups of~50% of spermatozoa had fibres with a normal structure; of patients had no such defect and thus did not improve after this figure did not change with therapy. In the immature therapy. A few extremely damaged spermatozoa with this responder group, however, after 12 weeks of therapy, the defect represented the final stages of post-apoptotic necrosis number of spermatozoa with normal fibres increased to 80% and this condition was unaffected by therapy.
(P Ͻ0.05).
Uncondensed chromatin: This negative characteristic is typical
Fibrous sheath: This is the other important cytoskeletal comof immature spermatozoa. Hence, FSH significantly improved ponent of the sperm tail. With regard to the accessory fibres, the chromatin condition in this group from 69.2 to 25.5% (P the fibrous sheath was correctely shaped in about half (range Ͻ 0.01). The other groups (apoptotic and infected spermato-43-57%) of the sperm population in our three groups of zoa), even among responders, showed no change in the level patients. Immediately after FSH therapy, there was a significant of this defect. improvement in the apoptotic patients (P Ͻ 0.05) which Absence of cytoplasmic residues: The presence of cytoplasmic remained consistent 6-12 weeks after the cessation of therapy. residues is usually a sign of immaturity. In our groups There were no significant improvements in the other two of responder patients, residues were absent in Ͼ80% of groups. spermatozoa, and remained stable after the FSH therapy. Only Plasma membrane integrity: In our three groups, plasma in the immature group, did the initial value of 73% increase membrane integrity was initially acceptable and responded to 85.5% (not significant).
positively to FSH. The plasma membrane integrity in patients Normal mitochondrial shape: Approximately 50% of the sperm with immature spermatozoa increased from almost 78 to 81% population had abnormally shaped mitochondria. In immature (not significant). In patients with infected semen, the level and in infected groups, there was no significant improvement increased from 66.6 to almost 74% (P Ͻ 0.05); in patients after FSH therapy. In the apoptotic group, therapy significantly with apoptotic spermatozoa, the level increased from 67.3 to improved the proportion of normal mitochondria from 40 to 76.5% (P Ͻ 0.05). The increase continued in the 6-12 weeks 62.40% (P Ͻ 0.01). This value was maintained 6 weeks after after the cessation of therapy to reach 84.3%. the cessation of therapy, with no further increase.
Regular mitochondrial assembly: A regular helicoidal assembly
Discussion of mitochondria is essential for normal sperm motility. Irregular helices are very frequent in sterile spermatozoa. In our three
The role of FSH in male fertility, and particularly in the quality groups of responder patients, 30-40% mitochondria showed of human spermatozoa, was approached by assessing the regular helicoidal assembly; this significantly improved after ultrastructure and consequently the function of infertile human FSH therapy in patients with immature or infected spermatozoa spermatozoa using the formula of Baccetti et al. (1995) . This was previously used to examine the relationship between sperm (P Ͻ 0.05), and in patients with apoptotic spermatozoa (P Ͻ ultrastructure and the success of different techniques of assisted micro-organisms on the germinal cells, leading to an improvement in sperm maturity. reproduction, and has proved to be very sensitive and useful (Strehler et al., 1995; Piomboni et al., 1996) . Recently other A third microscopic analysis was carried out 6-12 weeks after the cessation of therapy; in responders there was a further workers (Ombelet et al., 1995) have demonstrated that morphology assessed by strict criteria at light microscopy level is a improvement in the proportion of healthy spermatozoa (due to the amelioration of spermatogenesis at the end of FSH useful method for evaluating spermatological problems. Our work suggests that a better resolution is possible using our treatment), while the percentage of spermatozoa devoid of defects remained constant. In non-responders, the number of technique. In the present work, sperm structure has been used to monitor the andrological situation of patients leading to healthy spermatozoa continued to decrease. We used electron microscopy and statistical analysis to various conclusions.
Firstly, it is not advisable to classify infertile spermatozoa assess the reaction to FSH therapy of the individual organelles that contribute to the integrity of the spermatozoa. The first into a single category. Our submicroscopic examination of the sperm population in 81 patients (66 subject to FSH therapy, distinctive trait observed was that not all the defects affecting sperm organelles and causing male sterility, responded to FSH 15 to placebo treatment) demonstrated that at least five categories of major sperm defects could be distinguished prior in the same way. For example, the proportion of multiplyfused spermatozoa, of cytoplasmic residues, or of axonemes to therapy. We have defined these categories as immaturity, infection, apoptosis, autoantibodies, azoospermia due to spermrolled up around the sperm body did not respond to FSH therapy. atogenetic arrest. Each responded differently to FSH therapy, while placebo treatment had no effect upon the control group.
The characteristics of the acrosomal complex revealed a modest sensitivity to FSH therapy; only in those responders Microscopic analysis carried out after 12 weeks of FSH treatment showed a general improvement in the sperm populawith infected spermatozoa were significant improvements evident in acrosomal position, acrosomal shape and acrosomal tion of the 66 FSH-treated individuals (normal spermatozoa had increased from 0.23 to 1.26%. However, the 66 patients dimensions and in a decrease in the percentage of absent or reacted acrosomes. In the other categories, only in those fell into two distinct groups; those who responded to therapy and those who did not. In the responders group the mean patients with apoptotic spermatozoa was the acrosomal position significantly improved. number of normal spermatozoa increased from 0.16 to 1.71%, while the non-responders slightly decreased their initial value,
The nucleus was, on the contrary, quite reactive to FSH therapy; the nuclear shape significantly improved both in the in line with the placebo-treated control group.
When the five groups of patients, categorized according to apoptotic group and in the immature and infected groups. The improvement in the compaction of the chromatin was highly their sperm defects, were divided into responders and nonresponders to FSH therapy, the results were very interesting. significant in the immature sperm category, while the percentage of marginated chromatin, typical of apoptosis, significantly The four patients affected by immaturity and the 23 by apoptosis were all responders; those affected by autoantibodies decreased only in the apoptotic sperm group, where the greatest success of FSH therapy was evident. Uncondensed chromatin, (n ϭ 1) or by spermatogenetic arrest followed by azoospermia (n ϭ 3) were non-responders; those affected by microbial typical of immature spermatozoa, significantly decreased only in the immature sperm group, while disrupted chromatin infections could be found in both the responders (n ϭ 20) and non-responders (n ϭ 15). The positive response to FSH by diminished significantly only in the infected responders group. We know that the condition of the chromatin (upon which the immaturity group is in agreement with the data of Kliesch et al. (1992) , Russel et al. (1993) , Bartoov et al. (1994) and the nuclear shape depends) is closely correlated with sperm maturation, and is sensitive to apoptosis and infection. Singh and Handelsman (1996) who found that FSH stimulated initial spermatogenesis and improved sperm concentration, Mitochondria responded very well to FSH therapy; in the apoptotic sperm group, both the shape and the helicoidal gross morphology and motility. The general positive response of the apoptosis group is in line with a number of observations assembly significantly improved. Moreover, this latter characteristic improved both in the immature and the infected demonstrating that apoptosis is controlled by the concentration of FSH (Tapanainen et al., 1993; Billig et al., 1995;  Sinha sperm groups. Helix assembly is one of the most important consequences of spermiogenesis. Moreover, mitochondria are Hikim et al., 1995; Bartke, 1995) . The insensitivity to FSH therapy shown by the single individual carrying autoantibodies among the most sensitive organelles to apoptosis (Kerr et al., 1972; Wyllie, 1987) . on the sperm surface indicates that there is no correlation between FSH and autoantibodies. FSH had no effect in the Therapy also had an interesting effect on the two most important characteristics of the axoneme: the classic 9 ϩ 2 three azoospermic patients, who produced only spermatids due to spermiogenetic arrest. The most puzzling phenomenon pattern and the presence of regular dynein arms. The apoptotic sperm group significantly improved with regard to the first concerned the reaction to FSH shown by the 35 infected patients; 15 of them did not respond to therapy while 20 and particularly the second characteristic. The immature group also significantly improved with regard to the first and second patients did. There is no reason to assume that FSH cures infections, so that the positive (even if low) response of 20 characteristics. The response of the latter was not surprising, since axonemal assembly occurs during spermiogenesis, and patients was surprising. In all of them, the number of spermatozoa and their state of maturity was consistently increased.
is hormone-dependent. However, the response by the apoptotic group was more interesting, since the axoneme has so far not These improvements appeared to counteract the effects of been regarded as being sensitive to apoptosis (and consequently Finally, those patients whose semen is infected should be treated with antibiotics, checking their sperm quality after to FSH). The axoneme is one of the most complex and delicate cell structures, so that an immediate involvement in the treatment. As a general conclusion, we can therefore state that the size of the total sperm population cannot predict the success apoptotic phenomena is not surprising. Accessory fibres and the fibrous sheath are less affected by FSH therapy. In our of therapies or assisted reproduction procedures. Our attempt to evaluate spermatozoa carefully and to recognize single study, accessory fibres were significantly sensitive in the immature group, as was the fibrous sheath in the apoptotic sperm defects in patients is validated by this study on FSH therapy, which demonstrates the power of our procedure. Most patients. As far as the accessory fibres are concerned, the entire process of formation of these structures occurs during of the previous conflicting results reported are due to a lack of relevant discrimination of the different defects present in the spermatid stage and they then follow the fate of all organelles assembling during spermiation. Their improvement the spermatozoa of patients, and not assessing the likelihood of their response to the hormones. after FSH therapy was not surprising. The fibrous sheath seemed to be involved in the response to FSH only in the non-apoptotic groups of patients. This structure is made up of
